Kingfisher Capital LLC Has $5.48 Million Stock Position in Danaher Co. (NYSE:DHR)

Kingfisher Capital LLC lowered its position in shares of Danaher Co. (NYSE:DHR) by 5.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,701 shares of the conglomerate’s stock after selling 1,189 shares during the quarter. Danaher accounts for about 1.3% of Kingfisher Capital LLC’s holdings, making the stock its 24th largest position. Kingfisher Capital LLC’s holdings in Danaher were worth $5,477,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the company. Icon Wealth Advisors LLC lifted its holdings in shares of Danaher by 5.7% in the third quarter. Icon Wealth Advisors LLC now owns 3,612 shares of the conglomerate’s stock valued at $1,004,000 after purchasing an additional 195 shares in the last quarter. Skye Global Management LP raised its position in Danaher by 6.9% during the third quarter. Skye Global Management LP now owns 142,000 shares of the conglomerate’s stock valued at $39,479,000 after buying an additional 9,200 shares during the period. Rockefeller Capital Management L.P. lifted its stake in Danaher by 2.6% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 430,588 shares of the conglomerate’s stock worth $119,694,000 after acquiring an additional 10,756 shares in the last quarter. Teachers Insurance & Annuity Association of America acquired a new stake in Danaher during the 3rd quarter worth about $39,000. Finally, Vinva Investment Management Ltd increased its holdings in shares of Danaher by 7.9% in the 3rd quarter. Vinva Investment Management Ltd now owns 30,932 shares of the conglomerate’s stock valued at $8,520,000 after purchasing an additional 2,257 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several analysts recently commented on DHR shares. UBS Group decreased their price target on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. Wells Fargo & Company started coverage on shares of Danaher in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 target price for the company. KeyCorp upped their price target on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a research report on Thursday, October 31st. Finally, Barclays dropped their target price on Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average target price of $287.16.

Danaher Price Performance

NYSE DHR opened at $238.83 on Friday. The company has a market cap of $172.50 billion, a P/E ratio of 45.58, a P/E/G ratio of 4.39 and a beta of 0.85. Danaher Co. has a 1 year low of $215.68 and a 1 year high of $281.70. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The company has a fifty day simple moving average of $255.25 and a 200 day simple moving average of $259.52.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period last year, the business posted $2.02 earnings per share. The firm’s revenue was up 3.1% compared to the same quarter last year. On average, sell-side analysts predict that Danaher Co. will post 7.5 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.